Chairman emeritus Peter C. Farrell - 14 Nov 2025 Form 4 Insider Report for RESMED INC (RMD)

Role
Director
Signature
Peter C. Farrell, Chairman emeritus
Issuer symbol
RMD
Transactions as of
14 Nov 2025
Net transactions value
-$625,016
Form type
4
Filing time
18 Nov 2025, 16:59:27 UTC
Previous filing
13 Nov 2025
Next filing
24 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FARRELL PETER C Director 9001 SPECTRUM CENTER BLVD., SAN DIEGO Peter C. Farrell, Chairman emeritus 18 Nov 2025 0001186102

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $1,162,965 +11,442 +17% $101.64 77,552 14 Nov 2025 Direct F1
transaction RMD ResMed Common Stock Tax liability $1,787,980 -7,314 -9.4% $244.46 70,238 14 Nov 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -11,442 -100% $0.000000 0 14 Nov 2025 ResMed Common Stock 11,442 $101.64 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction represents Options automatically exercised pursuant to the award terms. Options are vested in full.
F2 Disposition to issuer for tax withholding and cost to exercise the options granted on 11/14/2018.
F3 Transaction represents Options automatically exercised pursuant to the award terms. Options are vested in full.